Department of Epidemiology and Biostatistics Seminar Series
Wednesday, April 10, 2024
2:30 PM-3:30 PM
Devan V. Mehrotra, PhD,
Biostatistics and Research Decision Sciences, Merck & Co., Inc., will present "Randomized Clinical Trials – Replacing Traditional Analyses with
Better Alternatives."
Increased efficiency in the clinical drug development process benefits
multiple stakeholders in the healthcare ecosystem. Biostatisticians can
contribute on that front by developing and implementing analyses of randomized
clinical trials that are substantially more powerful than their traditional
counterparts. I will illustrate this using examples from all phases of drug
development.
Bio: Devan Mehrotra is Vice President of Biostatistics at Merck. He is also an
Adjunct Professor of Biostatistics at the University of Pennsylvania. Over the
past 30 years, he has contributed to the research, development and regulatory
approval of medical drugs and vaccines across many therapeutic areas.
Please email Nancy Colon-Anderson at nanderson@drexel.edu for Zoom
information
Contact Information
Nancy Colon-Anderson
nanderson@drexel.edu